Document is current
Any future updates will be listed below
-
Authors
Gebre, Makda S. https://orcid.org/0000-0001-8520-2178
Rauch, Susanne
Roth, Nicole
Yu, Jingyou
Chandrashekar, Abishek https://orcid.org/0000-0001-7821-5552
Mercado, Noe B. https://orcid.org/0000-0001-7769-7326
He, Xuan
Liu, Jinyan
McMahan, Katherine
Martinot, Amanda https://orcid.org/0000-0001-6237-6191
Martinez, David R.
Giffin, Victoria https://orcid.org/0000-0002-9783-302X
Hope, David https://orcid.org/0000-0001-5654-1744
Patel, Shivani https://orcid.org/0000-0003-3475-1016
Sellers, Daniel
Sanborn, Owen
Barrett, Julia
Liu, Xiaowen https://orcid.org/0000-0001-6030-8179
Cole, Andrew C.
Pessaint, Laurent
Valentin, Daniel
Flinchbaugh, Zack
Yalley-Ogunro, Jake
Muench, Jeanne
Brown, Renita
Cook, Anthony
Teow, Elyse
Andersen, Hanne https://orcid.org/0000-0003-1103-9608
Lewis, Mark G. https://orcid.org/0000-0001-7852-0135
Boon, Adrianus C. M. https://orcid.org/0000-0002-4700-8224
Baric, Ralph S. https://orcid.org/0000-0001-6827-8701
Mueller, Stefan O.
Petsch, Benjamin
Barouch, Dan H. https://orcid.org/0000-0001-5127-4659
- License Information
-
More Information
Article History
Received: 13 August 2021
Accepted: 11 November 2021
First Online: 18 November 2021
Competing interests
: S.R., B.P., N.R. and S.O.M. are employees of CureVac AG, Tübingen, Germany, a publicly listed company developing mRNA-based vaccines and immunotherapeutics. Authors may hold shares in the company. S.R., B.P. and N.R. are inventors on several patents on mRNA vaccination and use thereof. The other authors declare no competing interests.
